vimarsana.com

Page 4 - மாஸ்ட் செல் செயல்படுத்தல் நோய்க்குறி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

GB Sciences, Inc : GB Sciences and Purisys Announce Preferred Supplier Relationship to Advance Cannabinoid-Containing Pharmaceuticals

GB Sciences, Inc.: GB Sciences and Purisys Announce Preferred Supplier Relationship to Advance Cannabinoid-Containing Pharmaceuticals Purisys will supply ultra-high purity cannabinoids for use in GB Sciences cannabinoid-containing, optimized therapeutic mixtures (OTM). LAS VEGAS, NV / ACCESSWIRE / April 20, 2021 / GB Sciences, Inc. (OTCQB:GBLX) and Purisys, LLC, the global industry leader in ultra-high purity, pharmaceutical grade cannabinoid supply, today announced that GB Sciences has selected Purisys as their preferred vendor for the active pharmaceutical ingredients ( APIs ) used in formulating GB Sciences proprietary, cannabinoid-containing, optimized therapeutic mixtures (OTM). CBD Molecule-GB Sciences To achieve standardization in our cannabinoid-containing, optimized therapeutic mixtures, GB Sciences is moving away from using materials extracted from the cannabis plant in favor of OTM formulations incorporating identical copies of the plant cannabinoids that can be cre

GB Sciences and Purisys Announce Preferred Supplier Relationship to Advance Cannabinoid-Containing Pharmaceuticals

GB Sciences and Purisys Announce Preferred Supplier Relationship to Advance Cannabinoid-Containing Pharmaceuticals
phoenixherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from phoenixherald.com Daily Mail and Mail on Sunday newspapers.

GB Sciences and Purisys Announce Preferred Supplier Relationship to Advance Cannabinoid-Containing Pharmaceuticals

GB Sciences and Purisys Announce Preferred Supplier Relationship to Advance Cannabinoid-Containing Pharmaceuticals
theusnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theusnews.com Daily Mail and Mail on Sunday newspapers.

Long COVID Dramatically Increases Cases Of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Long COVID Dramatically Increases Cases Of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome On 5th Annual Advocacy Week, bipartisan legislators set to make major funding announcement. News provided by Share this article Share this article LOS ANGELES, April 19, 2021 /PRNewswire/  As Long COVID brings renewed attention to the debilitating and chronic illness known as Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), a record number of advocates are virtually gathering on Capitol Hill for Solve M.E. s 5th Annual Advocacy Week Monday, April 19. Organizers believe the surge in Long COVID is driving more participation. Nearly one thousand advocates signed up to attend this year s Advocacy Week – nearly tripling 2020 numbers, with registrants representing 49 states, the District of Columbia and Puerto Rico. More than 60 percent of the advocates say it s their first time ever seeking a conversation with their member of Congress.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.